A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 20, 2012

Primary Completion Date

April 2, 2015

Study Completion Date

April 20, 2015

Conditions
Neoplasms
Interventions
DRUG

ZSTK474

Two arms, each with serial cohorts receiving escalating doses.

Trial Locations (2)

Unknown

National Cancer Center Hospital East, Kashiwa

The Cancer Institute Hospital of JFCR, Koto-ku

All Listed Sponsors
lead

Zenyaku Kogyo Co., Ltd.

INDUSTRY

NCT01682473 - A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies | Biotech Hunter | Biotech Hunter